<DOC>
	<DOCNO>NCT02526225</DOCNO>
	<brief_summary>The aim study evaluate safety effectivity Ginkgo diterpene lactone meglumine injection tn treatment acute ischemic stroke</brief_summary>
	<brief_title>A Safety Effective Study Ginkgolides Diterpene Lactone Meglumine Injection Treatment Ischemic Stroke .</brief_title>
	<detailed_description>After randomize 90 + 7 day mRS 0-1 point Primary Outcome Measure , evaluate safety effectivity Ginkgo diterpene lactone meglumine injection tn treatment acute ischemic stroke</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>1 . Aged 18 80 year age , gender limitedã€‚ 2 . Within 48 hour stroke onset ischemic stroke ( diagnosis standard Chinese medical association fourth national conference cerebrovascular disease ) ; 3 . The first onset , always obvious legacy stroke sequela ( mRS acuity onset 1 ) ; 4 . The degree nerve function defect score ( NIHSS ) score 4 24 point , body movement component ( NIHSS score paragraph 5 6 ) total score 2 point high ; 5 . Understand voluntarily sign informed consent . 1 . Head image study confirm , encephalitis , brain tumor , brain abscess cause similar symptom disease , confirm hemorrhagic cerebral infarction , epidural hematoma , intracranial hematoma , intraventricular hemorrhage , subarachnoid hemorrhage , etc . 2 . The serious disturbance consciousness ( Ia NIHSS score 2 point high ) ; 3 . With hemorrhagic disease bleeding tendency , low limb venous thrombosis ; 4 . Serious abnormal liver kidney function , liver function laboratory index ALT &gt; 3 ULN , renal laboratory ULN Cr &gt; 1.5 ) ; 5 . A history mental illness dementia patient ; 6 . Severe organ systemic disease , accompany organ system malignant tumor , ongoing antitumor treatment , estimate lifetime &lt; 3 month ; 7 . Significant drug alcohol abuse ; 8 . Allergic constitution , well two drug food allergy ; This medicine ingredients allergy know ; 9 . Have pregnancy ( check blood HCG positive screening test , namely HCG &gt; 5 miu/mL ) , test preparation pregnancy lactation woman ; 10 . In past three month clinical trial ; 11 . Researchers determine poor adherence , suitable patient participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>acute ischemic stroke</keyword>
	<keyword>safety effectiveness</keyword>
	<keyword>Ginkgo diterpene lactone meglumine injection</keyword>
</DOC>